EE200200693A - Interferoon hulgiskleroosi raviks - Google Patents

Interferoon hulgiskleroosi raviks

Info

Publication number: EE200200693A
Authority: EE; Estonia
Prior art keywords: interferon; treatment; multiple sclerosis; sclerosis
Prior art date: 2000-06-16

Application number

EEP200200693A

Other languages

English (en)

Inventor

M. Croze Edward

Faulds Daryl

Charis Wagner T.

Original Assignee

Schering Aktiengesellschaft

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-06-16

Filing date

2001-06-18

Publication date

2004-06-15

2001-06-18 Application filed by Schering Aktiengesellschaft filed Critical Schering Aktiengesellschaft

2004-06-15 Publication of EE200200693A publication Critical patent/EE200200693A/et

Links

102000014150 Interferons Human genes 0.000 title 1
108010050904 Interferons Proteins 0.000 title 1
229940079322 interferon Drugs 0.000 title 1
201000006417 multiple sclerosis Diseases 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/215—IFN-beta
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

EEP200200693A 2000-06-16 2001-06-18 Interferoon hulgiskleroosi raviks EE200200693A (et)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US21204600P	2000-06-16	2000-06-16
US09/881,050 US20020025304A1 (en)	2000-06-16	2001-06-15	Novel interferon for the treatment of multiple sclerosis
PCT/US2001/041022 WO2001095929A2 (en)	2000-06-16	2001-06-18	Interferon for treatment of multiple sclerosis

Publications (1)

Publication Number	Publication Date
EE200200693A true EE200200693A (et)	2004-06-15

Family

ID=26906704

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EEP200200693A EE200200693A (et)	2000-06-16	2001-06-18	Interferoon hulgiskleroosi raviks

Country Status (22)

Country	Link
US (1)	US20020025304A1 (et)
EP (1)	EP1289541A2 (et)
JP (1)	JP2004505021A (et)
KR (1)	KR20030009529A (et)
CN (1)	CN1436086A (et)
AU (1)	AU2001267099A1 (et)
BG (1)	BG107370A (et)
BR (1)	BR0111852A (et)
CA (1)	CA2413077A1 (et)
CZ (1)	CZ20024094A3 (et)
EE (1)	EE200200693A (et)
HU (1)	HUP0300787A2 (et)
IL (1)	IL152996A0 (et)
LT (1)	LT2002123A (et)
MX (1)	MXPA02012308A (et)
NO (1)	NO20025964L (et)
NZ (1)	NZ522849A (et)
PL (1)	PL359562A1 (et)
RU (1)	RU2003100517A (et)
SI (1)	SI21080A (et)
SK (1)	SK17612002A3 (et)
WO (1)	WO2001095929A2 (et)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7314613B2 (en) *	2002-11-18	2008-01-01	Maxygen, Inc.	Interferon-alpha polypeptides and conjugates
KR20050086498A (ko) *	2002-11-18	2005-08-30	맥시겐, 인크.	인터페론-알파 폴리펩티드 및 접합체
EP1712992A1 (en) *	2005-04-11	2006-10-18	Sony Ericsson Mobile Communications AB	Updating of data instructions
US8895700B2 (en)	2010-02-18	2014-11-25	Janssen Biotech, Inc.	Monkey homolog of human interferon omega
JP7166923B2 (ja)	2016-02-05	2022-11-08	オリオニスバイオサイエンシズビーブイ	標的療法剤およびその使用
WO2018141964A1 (en)	2017-02-06	2018-08-09	Orionis Biosciences Nv	Targeted chimeric proteins and uses thereof
WO2018144999A1 (en)	2017-02-06	2018-08-09	Orionis Biosciences, Inc.	Targeted engineered interferon and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6372206B1 (en) *	1989-03-02	2002-04-16	University Of Florida	Orally-administered interferon-TAU compositions and methods
CZ329596A3 (en) *	1994-05-10	1997-05-14	Immulogic Pharma Corp	Preparation for treating scattered sclerosis
JP2001526033A (ja) *	1997-12-08	2001-12-18	ジェネンテク・インコーポレイテッド	ヒトインターフェロン−イプシロンというｉ型インターフェロン
EE200000694A (et) *	1998-05-29	2002-06-17	Biogen, Inc.	Inimese rekombinantse iterferooni beeta-1a (IFN-ß-1a) formulatsioon
WO2000017361A2 (en) *	1998-09-18	2000-03-30	Zymogenetics, Inc.	Interferon-epsilon
AU2001255380A1 (en) *	2000-04-14	2001-10-30	Zymogenetics Inc.	Human interferon, zinf2

2001
- 2001-06-15 US US09/881,050 patent/US20020025304A1/en not_active Abandoned
- 2001-06-18 SK SK1761-2002A patent/SK17612002A3/sk unknown
- 2001-06-18 WO PCT/US2001/041022 patent/WO2001095929A2/en not_active Application Discontinuation
- 2001-06-18 PL PL01359562A patent/PL359562A1/xx not_active Application Discontinuation
- 2001-06-18 EE EEP200200693A patent/EE200200693A/et unknown
- 2001-06-18 HU HU0300787A patent/HUP0300787A2/hu unknown
- 2001-06-18 RU RU2003100517/15A patent/RU2003100517A/ru not_active Application Discontinuation
- 2001-06-18 KR KR1020027017090A patent/KR20030009529A/ko not_active Application Discontinuation
- 2001-06-18 MX MXPA02012308A patent/MXPA02012308A/es unknown
- 2001-06-18 CZ CZ20024094A patent/CZ20024094A3/cs unknown
- 2001-06-18 CA CA002413077A patent/CA2413077A1/en not_active Abandoned
- 2001-06-18 AU AU2001267099A patent/AU2001267099A1/en not_active Abandoned
- 2001-06-18 NZ NZ522849A patent/NZ522849A/en unknown
- 2001-06-18 JP JP2002510107A patent/JP2004505021A/ja active Pending
- 2001-06-18 IL IL15299601A patent/IL152996A0/xx unknown
- 2001-06-18 SI SI200120032A patent/SI21080A/sl not_active IP Right Cessation
- 2001-06-18 CN CN01811184A patent/CN1436086A/zh active Pending
- 2001-06-18 EP EP01944716A patent/EP1289541A2/en not_active Withdrawn
- 2001-06-18 BR BR0111852-8A patent/BR0111852A/pt not_active Application Discontinuation
2002
- 2002-12-02 LT LT2002123A patent/LT2002123A/xx unknown
- 2002-12-11 BG BG107370A patent/BG107370A/xx unknown
- 2002-12-12 NO NO20025964A patent/NO20025964L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
MXPA02012308A (es)	2003-04-25
US20020025304A1 (en)	2002-02-28
IL152996A0 (en)	2003-06-24
EP1289541A2 (en)	2003-03-12
CZ20024094A3 (cs)	2003-05-14
HUP0300787A2 (hu)	2003-07-28
NO20025964D0 (no)	2002-12-12
SK17612002A3 (sk)	2003-08-05
SI21080A (sl)	2003-06-30
RU2003100517A (ru)	2004-06-27
AU2001267099A1 (en)	2001-12-24
BR0111852A (pt)	2003-05-20
CA2413077A1 (en)	2001-12-20
LT2002123A (en)	2003-06-25
KR20030009529A (ko)	2003-01-29
WO2001095929A2 (en)	2001-12-20
BG107370A (en)	2003-11-28
PL359562A1 (en)	2004-08-23
CN1436086A (zh)	2003-08-13
WO2001095929A3 (en)	2002-10-10
NO20025964L (no)	2003-02-14
NZ522849A (en)	2004-05-28
JP2004505021A (ja)	2004-02-19

Publication	Publication Date	Title
DE60142412D1 (de)	2010-07-29	Stabilisiertes interleukin 2
IS7236A (is)	2004-04-28	Meðferðarfræðileg ísókínólínefnasambönd
IT1318649B1 (it)	2003-08-27	Composizioni farmaceutiche per il trattamento di mucositi e stomatiti.
EE05020B1 (et)	2008-06-16	Glburiidi ravimkoostis
NO20033205L (no)	2003-09-02	Terapeutiske kromanforbindelser
NO20032122D0 (no)	2003-05-12	Forbedret behandling
DE50209245D1 (de)	2007-02-22	Neuroprotektives medikament
DE60139339D1 (de)	2009-09-03	Stabilisierte interferonzusammensetzungen
DE60227963D1 (de)	2008-09-11	Behandlungssystem
EE200200693A (et)	2004-06-15	Interferoon hulgiskleroosi raviks
FR2791258B1 (fr)	2001-08-24	Composition amincissante
GB0014356D0 (en)	2000-08-02	Treatment of multiple sclerosis
ID30381A (id)	2001-11-29	Penggunaan arilalkanoilpiridazina
PL350883A1 (en)	2003-06-02	One-track roller-board
ITMI20011820A0 (it)	2001-08-28	Trattamento di ustioni
DE60207900D1 (de)	2006-01-19	"Suspend"-Paketübertrager
FR2828374B1 (fr)	2004-02-06	Bordure d'allee
NO20022643D0 (no)	2002-06-05	Reduksjonsprosess
IL136687A0 (en)	2001-06-14	Pharmaceutical composition for the treatment of multiple sclerosis
SE0102496D0 (sv)	2001-07-12	Utslagsramp
SE0100081L (sv)	2002-07-12	Utslagsramp
UA5412S (uk)	2001-11-15	Набір дорожнього посуду
SE0002001D0 (sv)	2000-05-26	Surface treatment composition
ITRC20010003A1 (it)	2001-05-22	"fumanello"
SE0103855D0 (sv)	2001-11-19	Therapeutic agents